Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis

Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis

Background: There are several selective serotonin reuptake inhibitor (SSRI) antidepressants currently used to treat binge eating disorder (BED), but the efficacy and acceptability of these antidepressants are still controversial. Therefore, we designed a network meta-analysis (NMA) to compare the ef...

Full description

Bibliographic Details
Main Authors:	Hanying Duan, Lijun Zhu, Min Li, Xinyue Zhang, Beilin Zhang, Shaokuan Fang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Pharmacology
Subjects:	selective serotonin reuptake inhibitor antidepressants binge eating disorder efficacy acceptability network meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.949823/full

Similar Items

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
by: Hugo R. Arias, et al.
Published: (2021-04-01)

The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices
by: Bianca Auschra, et al.
Published: (2022-03-01)

Evidence-based therapeutic management of binge-eating disorder
by: D. Vasile, et al.
Published: (2021-04-01)

Selective serotonin reuptake inhibitors suppress sharp wave ripples in the ventral hippocampus
by: Hiromi Shiozaki, et al.
Published: (2023-06-01)

Comparative analysis of the use of selective serotonin reuptake inhibitors during pregnancy and the postpartum period. Safety of sertraline
by: E. A. Ushkalova, et al.
Published: (2023-10-01)

Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history
by: D. S. Danilov
Published: (2018-12-01)

Acute Angle-Closure—A Rare but Vision-Threatening Ocular Adverse Effect of Selective Serotonin Reuptake Inhibitors
by: Michał Wiciński, et al.
Published: (2021-04-01)

Chirality in Modern Antidepressants: A Comprehensive Review of Stereochemical Impacts on Pharmacology and Therapeutics
by: Gabriel Hancu, et al.
Published: (2024-09-01)

In vitro, in vivo, and in silico approaches for evaluating the preclinical DMPK profiles of ammoxetine, a novel chiral serotonin and norepinephrine reuptake inhibitor
by: Xiuqing Zhu, et al.
Published: (2024-11-01)

New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
by: David Fanelli, et al.
Published: (2021-10-01)

Antidepressants with antimicrobial activity? A promising therapeutic strategy
by: Gloria M. González, et al.
Published: (2022-07-01)

Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history
by: D. S. Danilov
Published: (2015-03-01)

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
by: Azmeraw T. Amare, et al.
Published: (2018-03-01)

Decreased Growth with Serotonin Reuptake Inhibitors
by: J Gordon Millichap
Published: (2002-08-01)

The effect of selective serotonin and norepinephrine reuptake inhibitors on clinical outcome of COVID‐19 patients: A systematic review and meta‐analysis
by: Dena Firouzabadi, et al.
Published: (2022-11-01)

A case of severe paraneoplastic itch resistant to antihistamines and responding to serotonin reuptake inhibitors
by: Ines Werda, et al.
Published: (2021-07-01)

The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
by: Xiaotong Wen, et al.
Published: (2022-08-01)

Serotonin antidepressants and atrial fibrillation burden from cardiac implantable electronic devices
by: Youlin Koh, et al.
Published: (2023-12-01)

A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants
by: Li J, et al.
Published: (2024-11-01)

Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
by: Ravisha Wadhwa, et al.
Published: (2017-06-01)

Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year
by: Katja Werheid, et al.
Published: (2022-06-01)

Relationship between psychopathology and binge size in binge eating spectrum disorders
by: Carla L. Mourilhe Silva, et al.
Published: (2024-12-01)

Genetic polymorphism in the serotonin transporter gene-linked polymorphic region and response to serotonin reuptake inhibitors in patients with premature ejaculation
by: Emin Ozbek, et al.
Published: (2014-11-01)

Differentiated HT22 cells as a novel model for in vitro screening of serotonin reuptake inhibitors
by: Juhee Lim, et al.
Published: (2023-01-01)

Hyperpalatable Foods Consumption in a Representative Sample of the General Population in Brazil: Differences of Binge and Non-Binge Eating Meals
by: Carlos Eduardo Ferreira de Moraes, et al.
Published: (2023-02-01)

Clinical aspects of binge eating disorder: A cross-sectional mixed-methods study of binge eating disorder experts' perspectives
by: Brenna Bray, et al.
Published: (2023-02-01)

The Art of Accepting Oneself – Mindfulness and its use in Binge Eating
by: Beatriz Calado Araujo, et al.
Published: (2023-10-01)

Comparison of the neurobiological effects of attribution retraining group therapy with those of selective serotonin reuptake inhibitors
by: C. Wang, et al.
Published: (2013-03-01)

Selective serotonin reuptake inhibitors in children and adolescents
by: Swiss Medical Weekly
Published: (2002-08-01)

Selective serotonin reuptake inhibitors and spermatogenesis
by: M. N. Korshunov, et al.
Published: (2021-07-01)

Antidepressant class and concurrent rTMS outcomes in major depressive disorder: a systematic review and meta-analysisResearch in context
by: Alina Zaidi, et al.
Published: (2024-09-01)

Binge Eating, But Not Other Disordered Eating Symptoms, Is a Significant Contributor of Binge Drinking Severity: Findings from a Cross-Sectional Study among French Students
by: Benjamin Rolland, et al.
Published: (2017-10-01)

Neuroimaging in bulimia nervosa and binge eating disorder: a systematic review
by: Brooke Donnelly, et al.
Published: (2018-02-01)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
by: Stefania Chiappini, et al.
Published: (2022-05-01)

Effect of bariatric surgery on nutritional and metabolic parameters: does the type of antidepressant medication matter?
by: Katherine J. P. Schwenger, et al.
Published: (2024-07-01)

Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
by: Lisa Nicolai, et al.
Published: (2023-01-01)

Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness
by: Brian P. Brennan, et al.
Published: (2022-09-01)

Serotonin syndrome: An often-neglected medical emergency
by: Ahmed Badar
Published: (2024-01-01)

Topiramate: use in binge eating disorder?
by: Mauro Gentile, et al.
Published: (2012-01-01)

Mental health aspects of binge eating disorder: A cross-sectional mixed-methods study of binge eating disorder experts' perspectives
by: Brenna Bray, et al.
Published: (2022-09-01)